Thermo Fisher unveils assay panel to detect SARS-CoV-2 variants

LabPulse.com staff writers
Mar 9, 2021
2020 05 07 22 15 9104 Thermo Fisher Scientific 400

Thermo Fisher Scientific has announced the launch of a customizable menu of 22 real-time polymerase chain reaction (PCR) assays for the detection of SARS-CoV-2 mutations.

The Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel enables surveillance of virus variants that are being identified around the globe, allowing laboratories to choose which mutations to track.

The panel is designed to be highly scalable with the ability to run a few or hundreds of samples to identify one or many mutations.

Latest in COVID-19
Business Financial Stock Drop Social
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
March 21, 2023
Sars Co V 2 Spike Coronavirus Social
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
March 20, 2023
Fda Button Social
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
March 14, 2023
Gavel Resized
Chicago man indicted for COVID-19 testing fraud
March 14, 2023
Related Stories
2020 06 18 17 24 6922 Immunoassay Analysis 400
Pathology, histology
Thermo Fisher announces new suite of assays
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
Collaboration
Thermo Fisher expands leadership team
2020 07 02 23 31 0378 Handshake Meeting 400
Lab Software
Ortho inks deal with Thermo Fisher for QA software
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
Product Launch
Thermo Fisher announces Q1 revenue increase
More in COVID-19
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
The firm recorded an accounting impairment in Q4 for excess manufacturing and inventory related to the scale-up during peak COVID-19 testing demand and the decision to pause commercialization of its Amira COVID-19 test.
March 21, 2023
Business Financial Stock Drop Social
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
People who recover from SARS-CoV-2 infection and then get vaccinated are more protected than people who are unvaccinated, the researchers added.
March 20, 2023
Sars Co V 2 Spike Coronavirus Social
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Fda Button Social
Chicago man indicted for COVID-19 testing fraud
A Chicago lab that he co-owned obtained more then $83 million from the HRSA Uninsured Program as payment for COVID-19 tests purportedly performed by the laboratory, a U.S. Attorney's Office said.
March 14, 2023
Gavel Resized
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Covid 19 Spread Usa Social
COVID-19 leads to increased chest pain long after infection
In an ongoing effort to quantify long COVID’s impacts, nearly 150,000 patients were studied for cardiovascular symptoms following a COVID-19 infection.
March 6, 2023
Chest Heart Pain Social
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Quest launches long-COVID testing panels for consumers
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
More in COVID-19
Artificial intelligence tool identifies current drugs for future pandemics
Researchers have created an algorithmic tool that calculates how to effectively repurpose current drugs to combat COVID-19 and future pandemics.
March 6, 2023
Covid 19 Pill Social
COVID-19 vaccine development: Public funding yielded private profits
A BMJ study calculated U.S. public investments in pre-pandemic COVID-19 vaccine development and recommended policy reforms to maximize public health benefits.
March 1, 2023
Covid 19 Vaccine Distribution Transport Social
Collaborative research helps long-COVID patients recover
An NIH initiative called Researching COVID to Enhance Recovery (RECOVER) joins patients with researchers to better understand and treat long COVID.
March 3, 2023
Long Covid Brain Graphic Social
Immune-response test in study detects COVID-19 with near-perfect accuracy
A test that monitors the body’s molecular response to the SARS‑CoV‑2 virus can diagnose even asymptomatic patients with near-perfect accuracy, the researchers said.
March 1, 2023
Coronavirus Covid Blue Social
NanoSpot.ai launches AI-based SARS-CoV-2 antibody test
The test uses an agglutination-based method combined with an artificial intelligence (AI)-enabled mobile application to deliver semi-quantitative antibody test results at the point of care.
February 28, 2023
Covid 19 Antibody Social
University of Michigan breath analysis technology holds potential for COVID-19 detection
A diagnostic study indicates that a portable breath-based volatile organic compound monitor may have potential for COVID-19 detection.
March 1, 2023
Gas Chromatography Lab Social
Page 1 of 29
Next Page